Bladder Cancer Trial, Recruiting NCT05679557 Sponsor: Aarhus University Hospital Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT05679557
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with muscle-invasive bladder cancer and are scheduled to have their bladder surgically removed.
  • People whose surgical plan includes a specific type of urinary diversion called an ileal conduit (where a small piece of bowel is used to redirect urine out of the body).
  • People who are aged 65 years or older.
  • People who have been identified as frail based on a screening tool called the G8 (a score of 14 or below on this assessment).

Who may not be able to join:

  • People who are unwilling or unable to give formal written consent to take part in the study.
  • People who do not speak or understand Danish.
  • People whose surgical plan includes additional major procedures at the same time as the bladder removal, such as removal of a kidney and ureter.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jørgen S Bjerggaard Jensen, Prof., DMSc, Aarhus University Hospital and Aarhus University

Phone: +45 30915525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aarhus University Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2023
Est. completion
1 April 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Days Alive and out of Hospital (DAOH)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov